Director exercised or converted 30K ADMA derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 13, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 18, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-26-009900
Added to OQROOct 6, 2026, 9:54 PM UTC Data qualityVerified: identifiers matched exactly IssuerADMA BIOLOGICS, INC. Reporting personLawrence P. Guiheen SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateMar 13, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- The Reporting Person is exercising this option due, in part, to its near-term expiration date.
- These options vested in twenty-four equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.
Around the same time
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.
Gift or transfer — classified separately from trades.